Document is current
Any future updates will be listed below
-
Authors
Frostdahl, Hanna
Ahmad, Nouman
Hammar, Ulf
Mora, Andrés Martínez
Langner, Taro
Fall, Tove
Kullberg, Joel
Ahlström, Håkan
Brooke, Hannah L.
Ahmad, Shafqat
-
Funding
Funding for this research was provided by:
Göran Gustafsson Foundation
European Research council (GUTSY – 801965)
Vetenskapsrådet (2015–03477)
Vetenskapsrådet (2018-02784)
Vetenskapsrådet (2019-04756)
Vetenskapsrådet (2016-01040)
Vetenskapsrådet (2022-01460)
EXODIAB
Swedish Heart-Lung Foundation (20200500)
Swedish Heart-Lung Foundation (20220129)
Swedish Cancer Foundation (21 0456 FE)
FORMAS (2020-00989)
Epihealth
Uppsala University
- License Information
-
More Information
Article History
Received: 12 April 2024
Accepted: 22 July 2024
First Online: 1 August 2024
Competing interests
: Joel Kullberg and Håkan Ahlström are co-founders, co-owners of and part time employees of Antaros Medical AB, BioVenture Hub, Mölndal, Sweden. The other authors have no conflict of interest to report.
